Brca1 inactivation induces p27Kip1-dependent cell cycle arrest and delayed development in the mouse mammary gland

Oncogene

Volumn 23, Issue 36, 2004, Pages 6136-6145

  Deans, Andrew J ^a,b   Simpson, Kaylene J ^b   Trivett, Melanie K ^a   Brown, Melissa A ^c   McArthur, Grant A ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

BRCA1; Cell cycle; Mammary development; Mouse model; p27

Indexed keywords

BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE; PROTEIN P27;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CARCINOGENESIS; CELL CYCLE S PHASE; CELL PROLIFERATION; GENE FUNCTION; GENE INACTIVATION; HETEROZYGOTE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; WILD TYPE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPISTASIS, GENETIC; EPITHELIAL CELLS; GENES, BRCA1; HETEROZYGOTE; HUMANS; KINETICS; MAMMARY GLANDS, HUMAN; MAMMARY TUMOR VIRUS, MOUSE; MICE; MUTATION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS;

EID: 4444329645     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207805     Document Type: Article

References (52)

1. Armes JE and Venter DJ. (2002). Pathology, 34, 309-314.
2. Brown MA, Nicolai H, Howe K, Katagiri T, Lalani el N, Simpson KJ, Manning NW, Deans A, Chen P, Khanna KK, Wati MR, Griffiths BL, Xu CF, Stamp GW and Solomon E. (2002). Transgenic Res., 11, 467-478.
3. Brummelkamp TR, Bernards R and Agami R. (2002). Science, 296, 550-553.
4. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI and Slingerland JM. (1997). Nat. Med., 3, 227-230.
5. Chappuis PO, Kapusta L, Begin LR, Wong N, Brunet JS, Narod SA, Slingerland J and Foulkes WD. (2000). J. Clin. Oncol., 18, 4045-4052.
6. Chen A, Kleiman FE, Manley JL, Ouchi T and Pan ZQ. (2002). J. Biol. Chem., 277, 22085-22092.
7. Coats S, Flanagan WM, Nourse J and Roberts JM. (1996). Science, 272, 877-880.
8. Coqueret O. (2003). Trends Cell Biol., 13, 65-70.
9. Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K and Seth P. (1997). Oncogene, 14, 2283-2289.
10. Cressman VL, Backlund DC, Avrutskaya AV, Leadon SA, Godfrey V and Koller BH. (1999). Mol. Cell. Biol., 19, 7061-7075.
11. Crook T, Brooks LA, Crossland S, Osin P, Barker KT, Waller J, Philp E, Smith PD, Yulug I, Peto J, Parker G, Allday MJ, Crompton MR and Gusterson BA. (1998). Oncogene, 17, 1681-1689.
12. Davison EA, Lee CS, Naylor MJ, Oakes SR, Sutherland RL, Hennighausen L, Ormandy CJ and Musgrove EA. (2003). Mol. Endocrinol., 17, 2436-2447.
13. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C and Pandolfi PP. (2001). Nat. Genet., 27, 222-224.
14. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK and Shiekhattar R. (2003). Mol. Cell, 12, 1087-1099.
15. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D and Sobol H. (1996). Cancer Res., 56, 471-474.
16. Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID and Rosen EM. (2001). Oncogene, 20, 8215-8235.
17. Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ. (1998). Nature, 396, 177-180.
18. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K and Roberts JM. (1996). Cell, 85, 733-744.
19. Fujieda S, Inuzuka M, Tanaka N, Sunaga H, Fan GK, Ito T, Sugimoto C, Tsuzuki H and Saito H. (1999). Int. J. Cancer, 84, 315-320.
20. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J and Livingston DM. (2002). Cell, 111, 393-405.
21. Gowen LC, Johnson BL, Latour AM, Sulik KK and Koller BH. (1996). Nat. Genet., 12, 191-194.
22. Hakansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H and Borg A. (1997). Am. J. Hum. Genet., 60, 1068-1078.
23. Humphreys RC, Lydon J, O'Malley BW and Rosen JM. (1997). Mol. Endocrinol., 11, 801-811.
24. Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM and Pledger WJ. (2002). Oncogene, 21, 8486-8497.
25. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J and Liu ET. (2002). J. Natl. Cancer Inst., 94, 990-1000.
26. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V and Olsson H. (1997). Eur. J. Cancer, 33, 362-371.
27. Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J and Borg A. (2000). Cancer Res., 60, 5323-5328.
28. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D and Miller AD. :(1994). Proc. Natl. Acad. Sci. USA, 91, 7071-7075.
29. Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M and Nikai H. (2000). Cancer Lett., 151, 217-222.
30. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L and Easton DF. (2002). J. Clin. Oncol., 20, 2310-2318.
31. Liu DF, Ferguson K, Cooper GS, Grady WM and Willis J. (1999). J. Clin. Lab. Anal., 13, 291-295.
32. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC and Scheithauer BW. (1999). Am. J. Pathol., 154, 313-323.
33. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA and Lynch HT. (1996). Cancer, 77, 697-709.
34. Martins CP and Berns A. (2002). EMBO J., 21, 3739-3748.
35. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 3587-3596.
36. Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM and Arteaga CL. (2001). J. Cell Biol., 153, 917-932.
37. Nadeau G, Boufaied N, Moisan A, Lemieux KM, Cayanan C, Monteiro AN and Gaudreau L. (2000). EMBO Rep., 1, 260-265.
38. Niwa Y, Oyama T and Nakajima T. (2000). Jpn. J. Cancer Res., 91, 519-526.
39. Pharoah PD, Easton DF, Stockton DL, Gayther S and Ponder BA. (1999). Cancer Res., 59, 868-871.
40. Philipp-Staheli J, Kim KH, Payne SR, Gurley KE, Liggitt D, Longton G and Kemp CJ. (2002). Cancer Cell, 1, 355-368.
41. Russo J, Lynch H and Russo IH. (2001). Breast J., 7, 278-291.
42. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD. (1997). Proc. Natl. Acad. Sci. USA, 94, 5605-5610.
43. Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M and Livingston DM. (1999). Mol. Cell, 4, 1093-1099.
44. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
45. Slingerland J and Pagano M. (2000). J. Cell Physiol., 183, 10-17.
46. Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelenat H, Pouillart P, Vincent-Salomon A, Fourquet A and Asselain B. (2000). J. Clin. Oncol., 18, 4053-4059.
47. Sylvain V, Lafarge S and Bignon YJ. (2002). Int. J. Oncol., 20, 845-853.
48. Thornberry NA and Lazebnik Y. (1998). Science, 281, 1312-1316.
49. Vaziri SA, Tubbs RR, Darlington G and Casey G. (2001). Mol. Pathol., 54, 259-263.
50. Wagner T, Stoppa-Lyonnet D, Fleischmann E, Muhr D, Pages S, Sandberg T, Caux V, Moeslinger R, Langbauer G, Borg A and Oefner P. (1999). Genomics, 62, 369-376.
51. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A and Deng CX. (1999). Nat. Genet., 22, 37-43.
52. Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS and Li R. (2001). J. Cell Biol., 155, 911-921.